Standout Papers

Endothelial Dysfunction, ... 1997 2026 2006 2016 2001 2001 2003 1997 1999 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease
    2001 1.6k citations Thomas Heitzer, Thomas Meinertz et al. Circulation profile →
  2. Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
    2001 964 citations Ulrich Hink, Huige Li et al. Circulation Research profile →
  3. Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
    2003 791 citations Stephan Baldus, Christopher Heeschen et al. Circulation profile →
  4. Emergency Room Triage of Patients with Acute Chest Pain by Means of Rapid Testing for Cardiac Troponin T or Troponin I
    1997 766 citations Christian W. Hamm, Britta Goldmann et al. New England Journal of Medicine profile →
  5. Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis
    1999 574 citations Ascan Warnholtz, Georg Nickenig et al. Circulation profile →
  6. Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling
    2002 560 citations Hanke Mollnau, Maria Wendt et al. Circulation Research profile →
  7. High-Speed Rotational Atherectomy Before Paclitaxel-Eluting Stent Implantation in Complex Calcified Coronary Lesions
    2012 356 citations Mohamed Abdel‐Wahab, Gert Richardt et al. JACC: Cardiovascular Interventions profile →

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 108 hit
Sub-graph 1 of 14

Citing Papers

Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Hit
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Hit
67 intermediate papers

Works of Thomas Meinertz being referenced

Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial
2011
Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study)
2002
and 29 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas Meinertz 10.1k 3.8k 3.6k 2.6k 2.1k 305 17.7k
Todd J. Anderson 10.0k 1.0× 3.3k 0.9× 4.8k 1.3× 2.8k 1.1× 1.6k 0.7× 242 18.3k
Raffaele De Caterina 11.6k 1.2× 2.6k 0.7× 5.5k 1.5× 1.5k 0.6× 1.9k 0.9× 655 24.3k
Dimitris Tousoulis 9.0k 0.9× 3.4k 0.9× 3.9k 1.1× 1.9k 0.7× 2.3k 1.1× 809 20.3k
Keith M. Channon 8.3k 0.8× 6.0k 1.6× 4.8k 1.3× 1.8k 0.7× 3.4k 1.6× 490 23.0k
Hirofumi Yasue 15.2k 1.5× 3.8k 1.0× 4.4k 1.2× 2.2k 0.8× 1.2k 0.6× 420 23.7k
Javier Dı́ez 12.0k 1.2× 2.2k 0.6× 3.2k 0.9× 1.5k 0.6× 1.5k 0.7× 407 19.7k
Elena Tremoli 6.3k 0.6× 1.5k 0.4× 3.8k 1.1× 2.8k 1.1× 1.9k 0.9× 483 17.1k
Tsutomu Imaizumi 7.3k 0.7× 3.1k 0.8× 4.8k 1.3× 2.6k 1.0× 1.9k 0.9× 350 21.1k
Frank W. Sellke 7.0k 0.7× 2.5k 0.7× 5.9k 1.6× 2.2k 0.9× 2.6k 1.2× 574 22.6k
Philip S. Tsao 6.4k 0.6× 6.5k 1.7× 4.5k 1.2× 2.7k 1.0× 2.0k 0.9× 259 19.7k

All Works

Loading papers...

Rankless by CCL
2026